Abhik Roy1, Shilpa Mehra2, Ciarán P Kelly3, Sohaib Tariq3, Kumar Pallav3, Melinda Dennis3, Ann Peer3, Benjamin Lebwohl4, Peter H R Green4, Daniel A Leffler3. 1. Department of Gastroenterology, Columbia University, 622 West 168th Street, PH7 West (Room 318), New York, NY 10032, USA. 2. Division of Gastroenterology and Hepatology, Montefiore Medical Center, Bronx, NY, USA. 3. Division of Gastroenterology, Beth Israel Deaconess Medical Center, Boston, MA, USA. 4. Department of Gastroenterology, Columbia University, New York, NY, USA.
Abstract
BACKGROUND: There are little data on patient factors that impact diagnosis rates of celiac disease. This study aims to evaluate the association between patient socioeconomic status and the symptoms at diagnosis of celiac disease. METHODS: A total of 872 patients with biopsy-proven celiac disease were categorized based on the presence or absence of (1) diarrhea and (2) any gastrointestinal symptoms at diagnosis. Univariate and multivariate analyses were used to assess the association between socioeconomic status and symptoms. RESULTS: Patients without diarrhea at presentation had a higher mean per capita income (US$34,469 versus US$32,237, p = 0.02), and patients without any gastrointestinal symptoms had a higher mean per capita income (US$36,738 versus US$31,758, p < 0.01) compared with patients having such symptoms. On multivariable analysis adjusting for sex, age, autoimmune or psychiatric comorbidities, and income, per capita income remained a significant predictor of diagnosis without gastrointestinal symptoms (odds ratio: 1.71, 95% confidence interval: 1.17-2.50, p < 0.01), and it showed a trend towards significance in diagnosis without diarrhea (odds ratio: 1.40, 95% confidence interval: 0.98-2.02, p = 0.06). CONCLUSIONS: Patients with nonclassical symptoms of celiac disease are less likely to be diagnosed if they are of lower socioeconomic status. Celiac disease may be under-recognized in this population due to socioeconomic factors that possibly include lower rates of health-seeking behavior and access to healthcare.
BACKGROUND: There are little data on patient factors that impact diagnosis rates of celiac disease. This study aims to evaluate the association between patient socioeconomic status and the symptoms at diagnosis of celiac disease. METHODS: A total of 872 patients with biopsy-proven celiac disease were categorized based on the presence or absence of (1) diarrhea and (2) any gastrointestinal symptoms at diagnosis. Univariate and multivariate analyses were used to assess the association between socioeconomic status and symptoms. RESULTS:Patients without diarrhea at presentation had a higher mean per capita income (US$34,469 versus US$32,237, p = 0.02), and patients without any gastrointestinal symptoms had a higher mean per capita income (US$36,738 versus US$31,758, p < 0.01) compared with patients having such symptoms. On multivariable analysis adjusting for sex, age, autoimmune or psychiatric comorbidities, and income, per capita income remained a significant predictor of diagnosis without gastrointestinal symptoms (odds ratio: 1.71, 95% confidence interval: 1.17-2.50, p < 0.01), and it showed a trend towards significance in diagnosis without diarrhea (odds ratio: 1.40, 95% confidence interval: 0.98-2.02, p = 0.06). CONCLUSIONS:Patients with nonclassical symptoms of celiac disease are less likely to be diagnosed if they are of lower socioeconomic status. Celiac disease may be under-recognized in this population due to socioeconomic factors that possibly include lower rates of health-seeking behavior and access to healthcare.
Entities:
Keywords:
diarrhea; gluten-free diet; healthcare disparity; income
Authors: Kent D Katz; Shahrooz Rashtak; Brian D Lahr; L Joseph Melton; Patricia K Krause; Kristine Maggi; Nicholas J Talley; Joseph A Murray Journal: Am J Gastroenterol Date: 2011-03-01 Impact factor: 10.864
Authors: Janet M Choi; Benjamin Lebwohl; Jeffrey Wang; Susie K Lee; Joseph A Murray; Mark V Sauer; Peter H R Green Journal: J Reprod Med Date: 2011 May-Jun Impact factor: 0.142
Authors: Carlo Catassi; Deborah Kryszak; Otto Louis-Jacques; Donald R Duerksen; Ivor Hill; Sheila E Crowe; Andrew R Brown; Nicholas J Procaccini; Brigid A Wonderly; Paul Hartley; James Moreci; Nathan Bennett; Karoly Horvath; Margaret Burk; Alessio Fasano Journal: Am J Gastroenterol Date: 2007-03-13 Impact factor: 10.864
Authors: Elisabetta Rapiti; Gerald Fioretta; Robin Schaffar; Isabel Neyroud-Caspar; Helena M Verkooijen; Franz Schmidlin; Raymond Miralbell; Roberto Zanetti; Christine Bouchardy Journal: Cancer Date: 2009-12-01 Impact factor: 6.860
Authors: Benjamin Lebwohl; Yael R Nobel; Peter H R Green; Martin J Blaser; Jonas F Ludvigsson Journal: Am J Gastroenterol Date: 2017-10-31 Impact factor: 10.864
Authors: Loren G Rabinowitz; Haley M Zylberberg; Alan Levinovitz; Melissa S Stockwell; Peter H R Green; Benjamin Lebwohl Journal: Dig Dis Sci Date: 2017-12-14 Impact factor: 3.199
Authors: Elizabeth Golembiewski; Katie S Allen; Amber M Blackmon; Rachel J Hinrichs; Joshua R Vest Journal: JMIR Public Health Surveill Date: 2019-10-07